0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biological Indicators Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-36P9168
Home | Market Reports
Global Biological Indicators Market Insights and Forecast to 2028
BUY CHAPTERS

Global Biological Indicators Market Research Report 2026

Code: QYRE-Auto-36P9168
Report
2026-01-21
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biological Indicators Market Size

The global Biological Indicators market was valued at US$ 433 million in 2025 and is anticipated to reach US$ 643 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Biological Indicators Market

Biological Indicators Market

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Biological Indicators (BIs) play a critical role in sterilization validation and infection control, widely used in medical devices, pharmaceuticals, food processing, and life sciences laboratories. They assess the effectiveness of steam, dry heat, ethylene oxide (EO), hydrogen peroxide, and other sterilization methods, ensuring compliance with ISO 11138, USP, and FDA regulations.
Based on form factor, BIs can be categorized into Self-Contained Biological Indicators (SCBIs), BI Strips, and BI Suspensions. Among them, SCBIs are widely used due to their convenience, reduced contamination risk, and enhanced validation efficiency.
In terms of application, the medical sector dominates the market, as hospitals and medical device manufacturers must routinely validate sterilization equipment like autoclaves and plasma sterilizers. The pharmaceutical industry also has stringent requirements for sterilization, especially in injectable drugs, vaccines, and sterile drug production. Additionally, the food and beverage sector is increasingly adopting BIs to monitor sterilization efficiency in processing equipment, ensuring food safety and regulatory compliance.
Regionally, North America is the largest market, with a share nearly 55%. North America and Europe lead the market due to stringent medical regulations and high industry standards. The Asia-Pacific region (especially China and India) is experiencing rapid growth in the BI market, driven by expanding healthcare and pharmaceutical industries and evolving regulatory frameworks. Latin America and the Middle East are also emerging markets, benefiting from improvements in healthcare infrastructure.
Looking ahead, the BI industry is shifting toward more efficient, intelligent, and automated solutions. Rapid-read BIs, electronic BIs (E-BIs), and smart monitoring systems are gradually replacing traditional methods, reducing manual intervention, accelerating sterilization validation, and improving quality control. As pharmaceutical regulations tighten and medical device standards advance, the demand for BIs is expected to rise, ensuring a more reliable approach to sterilization validation and infection control worldwide.
This report delivers a comprehensive overview of the global Biological Indicators market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biological Indicators. The Biological Indicators market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Biological Indicators market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Biological Indicators manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Biological Indicators Market Report

Report Metric Details
Report Name Biological Indicators Market
Accounted market size in 2025 US$ 433 million
Forecasted market size in 2032 US$ 643 million
CAGR 5.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Self-Contained Biological Indicator
  • Biological Indicator Strip
  • Others
Segment by Application
  • Hospital
  • Pharma Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, Fuze Medical, Matachana, Hu-Friedy, Advanced Sterilization, Bag Health Care, Terragene, Andersen, GKE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Biological Indicators companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Biological Indicators Market growing?

Ans: The Biological Indicators Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Biological Indicators Market size in 2032?

Ans: The Biological Indicators Market size in 2032 will be US$ 643 million.

What is the Biological Indicators Market share by region?

Ans: Regionally, North America is the largest market, with a share nearly 55%.

Who are the main players in the Biological Indicators Market report?

Ans: The main players in the Biological Indicators Market are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, Fuze Medical, Matachana, Hu-Friedy, Advanced Sterilization, Bag Health Care, Terragene, Andersen, GKE

What are the Application segmentation covered in the Biological Indicators Market report?

Ans: The Applications covered in the Biological Indicators Market report are Hospital, Pharma Companies, Others

What are the Type segmentation covered in the Biological Indicators Market report?

Ans: The Types covered in the Biological Indicators Market report are Self-Contained Biological Indicator, Biological Indicator Strip, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Indicators Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Self-Contained Biological Indicator
1.2.3 Biological Indicator Strip
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biological Indicators Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharma Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Indicators Market Perspective (2021–2032)
2.2 Global Biological Indicators Growth Trends by Region
2.2.1 Global Biological Indicators Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Biological Indicators Historic Market Size by Region (2021–2026)
2.2.3 Biological Indicators Forecasted Market Size by Region (2027–2032)
2.3 Biological Indicators Market Dynamics
2.3.1 Biological Indicators Industry Trends
2.3.2 Biological Indicators Market Drivers
2.3.3 Biological Indicators Market Challenges
2.3.4 Biological Indicators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Indicators Players by Revenue
3.1.1 Global Top Biological Indicators Players by Revenue (2021–2026)
3.1.2 Global Biological Indicators Revenue Market Share by Players (2021–2026)
3.2 Global Top Biological Indicators Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Biological Indicators Revenue
3.4 Global Biological Indicators Market Concentration Ratio
3.4.1 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Indicators Revenue in 2025
3.5 Global Key Players of Biological Indicators Head Offices and Areas Served
3.6 Global Key Players of Biological Indicators, Products and Applications
3.7 Global Key Players of Biological Indicators, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Biological Indicators Breakdown Data by Type
4.1 Global Biological Indicators Historic Market Size by Type (2021–2026)
4.2 Global Biological Indicators Forecasted Market Size by Type (2027–2032)
5 Biological Indicators Breakdown Data by Application
5.1 Global Biological Indicators Historic Market Size by Application (2021–2026)
5.2 Global Biological Indicators Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Biological Indicators Market Size (2021–2032)
6.2 North America Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Biological Indicators Market Size by Country (2021–2026)
6.4 North America Biological Indicators Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Indicators Market Size (2021–2032)
7.2 Europe Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Biological Indicators Market Size by Country (2021–2026)
7.4 Europe Biological Indicators Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Biological Indicators Market Size (2021–2032)
8.2 Asia-Pacific Biological Indicators Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Biological Indicators Market Size by Region (2021–2026)
8.4 Asia-Pacific Biological Indicators Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Biological Indicators Market Size (2021–2032)
9.2 Latin America Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Biological Indicators Market Size by Country (2021–2026)
9.4 Latin America Biological Indicators Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Indicators Market Size (2021–2032)
10.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Biological Indicators Market Size by Country (2021–2026)
10.4 Middle East & Africa Biological Indicators Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Details
11.1.2 3M Business Overview
11.1.3 3M Biological Indicators Introduction
11.1.4 3M Revenue in Biological Indicators Business (2021–2026)
11.1.5 3M Recent Development
11.2 Getinge Group
11.2.1 Getinge Group Company Details
11.2.2 Getinge Group Business Overview
11.2.3 Getinge Group Biological Indicators Introduction
11.2.4 Getinge Group Revenue in Biological Indicators Business (2021–2026)
11.2.5 Getinge Group Recent Development
11.3 Cantel Medical
11.3.1 Cantel Medical Company Details
11.3.2 Cantel Medical Business Overview
11.3.3 Cantel Medical Biological Indicators Introduction
11.3.4 Cantel Medical Revenue in Biological Indicators Business (2021–2026)
11.3.5 Cantel Medical Recent Development
11.4 Mesa Laboratories
11.4.1 Mesa Laboratories Company Details
11.4.2 Mesa Laboratories Business Overview
11.4.3 Mesa Laboratories Biological Indicators Introduction
11.4.4 Mesa Laboratories Revenue in Biological Indicators Business (2021–2026)
11.4.5 Mesa Laboratories Recent Development
11.5 Steris
11.5.1 Steris Company Details
11.5.2 Steris Business Overview
11.5.3 Steris Biological Indicators Introduction
11.5.4 Steris Revenue in Biological Indicators Business (2021–2026)
11.5.5 Steris Recent Development
11.6 Fuze Medical
11.6.1 Fuze Medical Company Details
11.6.2 Fuze Medical Business Overview
11.6.3 Fuze Medical Biological Indicators Introduction
11.6.4 Fuze Medical Revenue in Biological Indicators Business (2021–2026)
11.6.5 Fuze Medical Recent Development
11.7 Matachana
11.7.1 Matachana Company Details
11.7.2 Matachana Business Overview
11.7.3 Matachana Biological Indicators Introduction
11.7.4 Matachana Revenue in Biological Indicators Business (2021–2026)
11.7.5 Matachana Recent Development
11.8 Hu-Friedy
11.8.1 Hu-Friedy Company Details
11.8.2 Hu-Friedy Business Overview
11.8.3 Hu-Friedy Biological Indicators Introduction
11.8.4 Hu-Friedy Revenue in Biological Indicators Business (2021–2026)
11.8.5 Hu-Friedy Recent Development
11.9 Advanced Sterilization
11.9.1 Advanced Sterilization Company Details
11.9.2 Advanced Sterilization Business Overview
11.9.3 Advanced Sterilization Biological Indicators Introduction
11.9.4 Advanced Sterilization Revenue in Biological Indicators Business (2021–2026)
11.9.5 Advanced Sterilization Recent Development
11.10 Bag Health Care
11.10.1 Bag Health Care Company Details
11.10.2 Bag Health Care Business Overview
11.10.3 Bag Health Care Biological Indicators Introduction
11.10.4 Bag Health Care Revenue in Biological Indicators Business (2021–2026)
11.10.5 Bag Health Care Recent Development
11.11 Terragene
11.11.1 Terragene Company Details
11.11.2 Terragene Business Overview
11.11.3 Terragene Biological Indicators Introduction
11.11.4 Terragene Revenue in Biological Indicators Business (2021–2026)
11.11.5 Terragene Recent Development
11.12 Andersen
11.12.1 Andersen Company Details
11.12.2 Andersen Business Overview
11.12.3 Andersen Biological Indicators Introduction
11.12.4 Andersen Revenue in Biological Indicators Business (2021–2026)
11.12.5 Andersen Recent Development
11.13 GKE
11.13.1 GKE Company Details
11.13.2 GKE Business Overview
11.13.3 GKE Biological Indicators Introduction
11.13.4 GKE Revenue in Biological Indicators Business (2021–2026)
11.13.5 GKE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biological Indicators Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Self-Contained Biological Indicator
 Table 3. Key Players of Biological Indicator Strip
 Table 4. Key Players of Others
 Table 5. Global Biological Indicators Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Biological Indicators Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Biological Indicators Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Biological Indicators Market Share by Region (2021–2026)
 Table 9. Global Biological Indicators Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Biological Indicators Market Share by Region (2027–2032)
 Table 11. Biological Indicators Market Trends
 Table 12. Biological Indicators Market Drivers
 Table 13. Biological Indicators Market Challenges
 Table 14. Biological Indicators Market Restraints
 Table 15. Global Biological Indicators Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Biological Indicators Market Share by Players (2021–2026)
 Table 17. Global Top Biological Indicators Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biological Indicators Revenue, 2025
 Table 18. Ranking of Global Top Biological Indicators Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Biological Indicators Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Biological Indicators, Headquarters and Area Served
 Table 21. Global Key Players of Biological Indicators, Products and Applications
 Table 22. Global Key Players of Biological Indicators, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Biological Indicators Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Biological Indicators Revenue Market Share by Type (2021–2026)
 Table 26. Global Biological Indicators Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Biological Indicators Revenue Market Share by Type (2027–2032)
 Table 28. Global Biological Indicators Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Biological Indicators Revenue Market Share by Application (2021–2026)
 Table 30. Global Biological Indicators Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Biological Indicators Revenue Market Share by Application (2027–2032)
 Table 32. North America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Biological Indicators Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Biological Indicators Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Biological Indicators Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Biological Indicators Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Biological Indicators Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Biological Indicators Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Biological Indicators Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Biological Indicators Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Biological Indicators Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Biological Indicators Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Biological Indicators Market Size by Country (US$ Million), 2027–2032
 Table 47. 3M Company Details
 Table 48. 3M Business Overview
 Table 49. 3M Biological Indicators Product
 Table 50. 3M Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 51. 3M Recent Development
 Table 52. Getinge Group Company Details
 Table 53. Getinge Group Business Overview
 Table 54. Getinge Group Biological Indicators Product
 Table 55. Getinge Group Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 56. Getinge Group Recent Development
 Table 57. Cantel Medical Company Details
 Table 58. Cantel Medical Business Overview
 Table 59. Cantel Medical Biological Indicators Product
 Table 60. Cantel Medical Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 61. Cantel Medical Recent Development
 Table 62. Mesa Laboratories Company Details
 Table 63. Mesa Laboratories Business Overview
 Table 64. Mesa Laboratories Biological Indicators Product
 Table 65. Mesa Laboratories Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 66. Mesa Laboratories Recent Development
 Table 67. Steris Company Details
 Table 68. Steris Business Overview
 Table 69. Steris Biological Indicators Product
 Table 70. Steris Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 71. Steris Recent Development
 Table 72. Fuze Medical Company Details
 Table 73. Fuze Medical Business Overview
 Table 74. Fuze Medical Biological Indicators Product
 Table 75. Fuze Medical Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 76. Fuze Medical Recent Development
 Table 77. Matachana Company Details
 Table 78. Matachana Business Overview
 Table 79. Matachana Biological Indicators Product
 Table 80. Matachana Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 81. Matachana Recent Development
 Table 82. Hu-Friedy Company Details
 Table 83. Hu-Friedy Business Overview
 Table 84. Hu-Friedy Biological Indicators Product
 Table 85. Hu-Friedy Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 86. Hu-Friedy Recent Development
 Table 87. Advanced Sterilization Company Details
 Table 88. Advanced Sterilization Business Overview
 Table 89. Advanced Sterilization Biological Indicators Product
 Table 90. Advanced Sterilization Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 91. Advanced Sterilization Recent Development
 Table 92. Bag Health Care Company Details
 Table 93. Bag Health Care Business Overview
 Table 94. Bag Health Care Biological Indicators Product
 Table 95. Bag Health Care Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 96. Bag Health Care Recent Development
 Table 97. Terragene Company Details
 Table 98. Terragene Business Overview
 Table 99. Terragene Biological Indicators Product
 Table 100. Terragene Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 101. Terragene Recent Development
 Table 102. Andersen Company Details
 Table 103. Andersen Business Overview
 Table 104. Andersen Biological Indicators Product
 Table 105. Andersen Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 106. Andersen Recent Development
 Table 107. GKE Company Details
 Table 108. GKE Business Overview
 Table 109. GKE Biological Indicators Product
 Table 110. GKE Revenue in Biological Indicators Business (US$ Million), 2021–2026
 Table 111. GKE Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Biological Indicators Picture
 Figure 2. Global Biological Indicators Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Biological Indicators Market Share by Type: 2025 vs 2032
 Figure 4. Self-Contained Biological Indicator Features
 Figure 5. Biological Indicator Strip Features
 Figure 6. Others Features
 Figure 7. Global Biological Indicators Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Biological Indicators Market Share by Application: 2025 vs 2032
 Figure 9. Hospital Case Studies
 Figure 10. Pharma Companies Case Studies
 Figure 11. Others Case Studies
 Figure 12. Biological Indicators Report Years Considered
 Figure 13. Global Biological Indicators Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Biological Indicators Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Biological Indicators Market Share by Region: 2025 vs 2032
 Figure 16. Global Biological Indicators Market Share by Players in 2025
 Figure 17. Global Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Biological Indicators Revenue in 2025
 Figure 19. North America Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Biological Indicators Market Share by Country (2021–2032)
 Figure 21. United States Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Biological Indicators Market Share by Country (2021–2032)
 Figure 25. Germany Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Biological Indicators Market Share by Region (2021–2032)
 Figure 33. China Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Biological Indicators Market Share by Country (2021–2032)
 Figure 41. Mexico Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Biological Indicators Market Share by Country (2021–2032)
 Figure 45. Israel Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. 3M Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 49. Getinge Group Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 50. Cantel Medical Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 51. Mesa Laboratories Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 52. Steris Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 53. Fuze Medical Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 54. Matachana Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 55. Hu-Friedy Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 56. Advanced Sterilization Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 57. Bag Health Care Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 58. Terragene Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 59. Andersen Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 60. GKE Revenue Growth Rate in Biological Indicators Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS